feed,title,long_url,short_url
BioRxiv,Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant,https://biorxiv.org/cgi/content/short/2021.12.23.473991v1?rss=1,https://j.mp/3sv8BQd
BioRxiv,In vitro evolution predicts emerging CoV-2 mutations with high affinity for ACE2 and cross-species binding,https://biorxiv.org/cgi/content/short/2021.12.23.473975v1?rss=1,https://j.mp/3JiUxiv
BioRxiv,Potential coupling between SARS-CoV-2 replicative fitness and interactions of its nucleoprotein with human 14-3-3 proteins,https://biorxiv.org/cgi/content/short/2021.12.23.474009v1?rss=1,https://j.mp/3EuBvlU
BioRxiv,An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants,https://biorxiv.org/cgi/content/short/2021.12.25.474052v1?rss=1,https://j.mp/3mzWKfT
BioRxiv,IL4I1 binds to TMPRSS13 and competes with SARS-Cov2 Spike,https://biorxiv.org/cgi/content/short/2021.12.23.473686v1?rss=1,https://j.mp/3EzMHhe
BioRxiv,Human KIR+CD8+ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19,https://biorxiv.org/cgi/content/short/2021.12.23.473930v1?rss=1,https://j.mp/3ppJDQk
